Novonesis: Industry Leader With Defensive Characteristics And Solid Growth

2025-06-01 07:01:45 ET

Summary

• Novonesis is a global market leader in enzymes and biosolutions, offering defensive growth and resilience across essential industries like food, agriculture, and household care.
• The company has delivered strong organic growth, repeatedly raising guidance, and boasts high margins, robust R&D investment, and a shareholder-friendly, long-term focused strategy.
• Despite its strengths, Novonesis trades at a premium valuation (forward P/E ~40), making the current price uncomfortable for a full position; averaging in is recommended.
• I see substantial long-term potential, but would wait for a 10-15% pullback before initiating a full position, given the elevated valuation risk.

Introduction

Novonesis A/S ( NVZMF )( NVZMY ) isn’t the most covered of stocks here on Seeking Alpha. In fact, the company hasn’t received coverage since early February. More likely than not, this is because we’re dealing with a non-US based company with a FY2024 revenue of €3.9 billion and a market cap just above $30 billion, while acting as an enabler for a lot of different industries, therefore not taking the spotlight....

Read the full article on Seeking Alpha

For further details see: